Skip to main content

Table 2 MNAT1 expressions in CRC samples at various clinical stages

From: MNAT1 is overexpressed in colorectal cancer and mediates p53 ubiquitin-degradation to promote colorectal cancer malignance

Characteristic Cases MNAT1 expression p
Low(%) High(%)
All patients
 Gender
  Male 57 35(61.4) 22(38.6) 0.817
  Female 43 29(67.4) 14(32.6)  
 Age (yrs)
   < 50 34 16(47.1) 18(52.9) 0.770
   ≥ 50 66 35(53.0) 31(47.0)  
 T stage
  T1-T2 37 19(51.3) 18(48.7) 0.882
  T3-T4 63 34(53.9) 29(46.1)  
 N stage
  N0 39 17(43.6) 22(56.4) 0.891
  N1-N3 61 29(47.5) 32(52.5)  
 M stage
  M0 34 18(52.9) 16(47.1) 0.897
  M1 66 35(53.0) 31(47.0)